Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.

Justine L Kuiper Merle I Ronden Annemarie Becker Daniëlle A M Heideman Peter van Hengel Bauke Ylstra Erik Thunnissen Egbert F Smit

J Clin Pathol

Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands Department of Pulmonary Diseases, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Published: April 2015

Download full-text PDF	Source
http://dx.doi.org/10.1136/jclinpath-2015-202866	DOI Listing

Publication Analysis

Top Keywords

transformation squamous

squamous cell

cell carcinoma

carcinoma phenotype

phenotype egfr-mutated

egfr-mutated nsclc

nsclc patient

patient treatment

treatment egfr-tyrosine

egfr-tyrosine kinase

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!